Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Fixed Capital/Sales

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.800.890.940.760.60

What is the latest Fixed Capital/Sales ratio of CONCORD BIOTECH ?

The latest Fixed Capital/Sales ratio of CONCORD BIOTECH is 0.80 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.80
Mar20230.89
Mar20220.94
Mar20210.76
Mar20200.60

How is Fixed Capital/Sales of CONCORD BIOTECH Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.8
-10.11
Mar2023 0.89
-5.32
Mar2022 0.94
23.68
Mar2021 0.76
26.67
Mar2020 0.6 -

Other Financial Ratios of CONCORD BIOTECH


Compare Fixed Capital/Sales ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹21,939.3 Cr 9.9% 2.4% 44.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,132.0 Cr -2.4% -7.2% 27.2% Stock Analytics
DIVIS LABORATORIES ₹149,254.0 Cr 0% -9.2% 61.5% Stock Analytics
CIPLA ₹116,123.0 Cr 6% -3.8% 10.7% Stock Analytics
DR REDDYS LABORATORIES ₹100,573.0 Cr 1.7% -11.4% 2.2% Stock Analytics
ZYDUS LIFESCIENCES ₹97,966.9 Cr 5.2% -2.1% 26.1% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

9.9%

2.4%

44.8%

SENSEX

2.8%

-3.1%

9%


You may also like the below Video Courses